Concepedia

S. Klijn

SK

6

Publications

231

Citations

6

H-Index

2015

Active since

Affiliations

Bristol-Myers Squibb (United Kingdom)(Current)

Bristol-Myers Squibb (United States)

Pharmerit (Netherlands)

S. Klijn is an author at Bristol-Myers Squibb (United Kingdom) specializing in oncology, cancer research, and radiation oncology.

ORCID

Top concepts

Publications per year

2015–2024

6

Publications

6

Introducing the fit-criteria assessment plot – A visualisation tool to assist class enumeration in group-based trajectory modelling

S. Klijn, Matty P. Weijenberg, Paul Lemmens et al. · Statistical Methods in Medical Research · 2015 · 85 citations · Full text

, , +18

Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models

Tim Reason, Emma Benbow, Julia Langham et al. · PharmacoEconomics - Open · 2024 · 54 citations · Full text

A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies

Stephen Palmer, Isabelle Borget, Tim Friede et al. · Value in Health · 2022 · 34 citations · Full text

, , +9

Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models

Tim Reason, William D. Rawlinson, Julia Langham et al. · PharmacoEconomics - Open · 2024 · 24 citations · Full text

What Did Time Tell Us? A Comparison and Retrospective Validation of Different Survival Extrapolation Methods for Immuno-Oncologic Therapy in Advanced or Metastatic Renal Cell Carcinoma

S. Klijn, Elisabeth Fenwick, Sonja Kroep et al. · PharmacoEconomics · 2021 · 22 citations

, , +8

Rows per page

1–5 of 6